Hemispheric is developing a foundational AI platform for decoding the brain.Our products are designed to usher in a new era of precision medicine for brain health.

Recruited by and reporting to the CEO, spearheaded the creation of a Digital Business Unit and oversaw product portfolio strategy, business development, product development, and product management related to digital medicine, digital therapeutics, and digital health solutions. Established and supervised digital discovery team with expertise in development of digital health products to support disease prevent, management, and treatment. Responsibilities extended across several healthcare areas spanning businesses that covered medical devices, nutraceuticals, and pharmaceuticals.

Founded and led a digital therapeutics startup that brought together world respected scientists, technologists and businesspeople to pioneer the use of new and emerging digital technologies for serious mental illness. Products in early stage development leveraged augmented reality/virtual reality with a focus on schizophrenia, suicidality, bipolar disorder and peripartum depression.

Member of the Executive Leadership Team with responsibility for leading the company medical device division, including oversight and management of Software in a Medical Device (SiMD) Business Unit. Provided leadership oversight covering Clinical R&D, government affairs, DoD/VA Initiatives, strategic research partnerships, regulatory affairs, medical affairs, academic alliances, multiple NIH partnerships, Market Access and Reimbursement.  - Awarded and served as Principle Investigator on 2 NIH/NIDA research programs aimed at leveraging immersive technology as an opioid sparing solution to treat pain and address the opioid crisis. - Led National Cancer Institute co-development partnership to design and develop novel digital therapeutics to treat psychosocial aspects of disease in neuro-oncology - Established and oversaw Wounded Warrior initiative to develop virtual reality products with the Defense Health Agency and US Department of Veterans Affairs to treat behavioral health conditions in the military and veteran population - Partnered with elite academic institutions across the United States to advance the science of virtual reality and develop research programs to explore VR as a treatment for serious diseases.

Responsible for establishing and leading company-wide efforts to expand consumer mobile health opportunities within healthcare as well as develop clinically-validated, FDA-cleared, prescription digital medicine therapeutics. Founded Headspace Health, a subsidiary company of Headspace where I oversaw digital medicine strategy, including R&D, regulatory strategy, Payor analysis and negotiations, portfolio planning, commercialization strategy, KOL relations, medical communications, patient advocacy, and health system adoption. Led team assigned to wearables and device integration. Company lead for FDA discussions on technology platform PreCert and SaMD submissions.

Recruited to lead President’s University-wide Innovation Initiative and oversee industry healthcare partnerships and technology transfer, spanning pharmaceuticals, medical diagnostics and devices, with a focus on IT and digital medicine. Served as Lead of Johns Hopkins-Abbvie breakthrough oncology partnership.- Responsible for prospecting, building, shaping, and managing large ($25m+) JH-Pharma alliances that involve multiple therapeutic areas and bring University faculty from across multiple schools together to collaborate on novel products, services, and technologies to advance healthcare systems and improve patient treatment outcomes. - Lead University-wide efforts to advance HealthIT and mHealth initiatives through strategic corporate partnerships, technology development, DreamIT startups, technology licensing and a unique incubator program. - Established major University-wide strategic partnership with Luminox, a leading Israeli digital medicine incubator to accelerate 10 HealthIT startups and co-develop up to 20 disruptive technology solutions, including in the areas of wearables for clinical trials, medication adherence, braintech, and telehealth. Partnership formally endorsed by visionary Israeli President Shimon Peres. - Supported the formation and served as a strategic advisor to Hexcite, a unique health tech-focused accelerator for entrepreneurial medical residents and faculty - Business Development Lead on $100M+ “ICU of the Future” designing next-gen integrated hospital with advanced IoT technologies through a strategic partnership with Microsoft.- Led commercial, partnership, and business strategy for Hopkins InHealth, a big data precision medicine AI/ML platform aimed at leveraging patient, provider, and payor data to drive improved patient outcomes and increase healthcare efficiencies. Work led to $MM strategic partnership with Microsoft that transformed biomedical research, oncology, and specialty medical care at Johns Hopkins Hospital.

Promoted to direct international business development throughout the university, with a focus on healthcare, clinical research, and improving patient treatment outcomes through novel and emerging technology. Managed industry-supported public-private global projects such as research collaborations, international academic alliances, healthcare and entrepreneurship capacity building programs, global innovation conferences, and various initiatives in Asia, Europe, and Africa. Developed and promoted several faculty-led programs on health and social policy issues in Botswana, China, India, Rwanda, and Vietnam. Built and managed pioneering telehealth partnership with Microsoft to introduce telemedicine in rural African villages via cutting-edge White-Space technology. Established and maintained more than 75 partnerships with Fortune 500 companies, corporate foundations, leading NGOs, aimed at innovating new approaches and technology-based solutions to solve global social crises, including food insecurity, infant mortality, mental health stigma, HIV/AIDS in Africa, cervical cancer, and access to medical care.

Co-founded international academic center to improve the public understanding of neuroscience on society, research and education. Directed day-to-day operations and staff including faculty. Led business planning, fundraising, marketing and communications strategies and directed educational initiatives and partnerships. Served as a co-chair on the Advisory Board. Raised $1m seed investment and maintained full P&L responsibility.

Served as a member of the Marketing Practices and Innovations Department and led Neuroscience launch effort around worldwide opinion leader relations. Produced strategic planning on U.S. launch and lifecycle management for Bifeprunox and Pristiq. Led the Japan Project Oversight Team (JPOT) established to bring a deep empathetic lens to further understand and identify opportunities in the neuroscience marketplace in Asia. Oversaw North American, EU and Asia-Pac Neuroscience Opinion Leader Strategy aimed at generating innovation insights and paving the way for novel product launches. - Played a key role on worldwide opinion leader strategy to successfully launch the global brand, Pristiq. - Formed the Center of Excellence Initiative and created an oversight team in China and Japan to establish academic partnerships and Centers of Excellence. - Transformed opinion leader benchmarking and value assessment efforts that shaped engagement strategies across brands

First commercial hire and key player of the VIVITROL marketing launch team established to treat alcoholism. Directed U.S. launch strategy and methods to target the healthcare providers. Oversaw on and off-line promotional marketing tactics, branding, and outreach strategy for consumer and healthcare providers. Continually shaped relationships with key opinion leaders, patient advocacy group, academic and third-party organizations. - Oversaw omnichannel marketing including consumer and professional digital strategy- Responsible pre-lunch activities including market research, competitive landscape, public and patient advocacy - Developed and implemented unique CRM-based sales model for key influencers in treatment decision pathway. - Trained sales force on disease state, psychosocial dimensions, and non-traditional treatment approaches.

Directed a 4-member team to manage a global think tank with a focus on innovative digital health technology. Produced some of the very first mobile health apps ever conceived, such as OsteoEx® (a customized prescription), CardioRAP™ (a treatment algorithm), and DocBeam™ (a medical education tool). Supported Aventis Global MAX Brand Teams through developing consumer and professional digital solutions designed to improve treatment outcomes and better patient-physician interactions. Presented with the Aventis Achievement Award and additionally honored with three global innovation patents for eHealth technologies.